BBT001 in Healthy Volunteers and in Adult Patients with Atopic Dermatitis

2025-522918-23-00 Protocol BBT001-001 Human pharmacology (Phase I) - First administration to humans Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 4 sites · Protocol BBT001-001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Authorised, recruitment pending
Participants planned 92
Countries 1
Sites 4

Atopic Dermatitis

Key facts

Sponsor
Bambusa Therapeutics Inc.
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Skin and Connective Tissue Diseases [C17]
Decision date (initial)
2025-11-21
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2025-522918-23-00
ClinicalTrials.gov
NCT06808477

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Atopic Dermatitis

VersionLevelCodeTermSystem organ class
21.1 LLT 10003639 Atopic dermatitis 10040785

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Bambusa Therapeutics Inc.

2 Total trials
Commercial
Sponsor organisation
Bambusa Therapeutics Inc.
Address
22 Boston Wharf Road Floor 7
City
Boston
Postcode
02210-3032
Country
United States

Scientific contact point

Organisation
Bambusa Therapeutics Inc.
Contact name
Thang Ho

Public contact point

Organisation
Bambusa Therapeutics Inc.
Contact name
Lisa Li

Locations

1 EU/EEA country · 4 investigational sites

By country

CountryMS statusPlanned subjectsSites
Poland Authorised, recruitment pending 10 4
Rest of world
China, New Zealand, Australia, United States
82

Investigational sites

Poland

4 sites · Authorised, recruitment pending
Wojewodzki Specjalistyczny Szpital Im Dr Wl Bieganskiego
Oddzial Dermatologii, Dermatologii Dzieciecej i Onkologicznej, Ul. Gen. Karola Kniaziewicza 1/5, 91-347, Lodz
Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie
Klinika Dermatologii i Dermatologii Onkologicznej,, Ul. Fryderyka Szopena 2, 35-055, Rzeszow
Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak sp.p.
Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spolka Partnerska, Ul. Ul. Sliczna 13, 50-566, Wroclaw
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji
Klinika Dermatologii, Ul. Woloska 137, 02-507, Warsaw

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-07-31 Poland Acceptable
2025-11-17
2025-11-21
2 SUBSTANTIAL MODIFICATION SM-4 2025-12-19 Poland Acceptable
2026-03-02
2026-03-07